Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans...